language-icon Old Web
English
Sign In

Evidence-Based Management

2020 
This chapter primarily focuses on the evidence-based management of patients suffering from rosacea. We divide the chapter into topical followed by systemic therapies. Topical therapies include metronidazole, azelaic acid, ivermectin, calcineurin inhibitors, clindamycin, and more. Systemic therapies include tetracyclines, azithromycin, isotretinoin, and antihypertensives. Each individual section references recent literature supporting both positive and negative results. This chapter allows the reader to have a better understanding of different treatment regimens with valid (or quality) evidence to support (or not support) the use of each individual medication.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    90
    References
    0
    Citations
    NaN
    KQI
    []